Sperm-derived SPANX-B is a clinically relevant tumor antigen that is expressed in human tumors and readily recognized by human CD4 + and CD8 + T cells

Clinical Cancer Research

Volumn 15, Issue 6, 2009, Pages 1954-1963

  Almanzar, Giovanni ^a   Olkhanud, Purevdorj B ^a   Bodogai, Monica ^a   Dellagnola, Chiara ^c   Baatar, Dolgor ^a   Hewitt, Stephen M ^b   Ghimenton, Claudio ^d   Tummala, Mohan K ^a   Weeraratna, Ashani T ^a   Hoek, Keith Sean ^e   Kouprina, Natalay ^b   Larionov, Vladimir ^b   Biragyn, Arya ^a,f  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF VERONA   (Italy)

^d Civile Maggiore Hospital   (Italy)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^f NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; EPITOPE; HLA A2 ANTIGEN; HLA DR ANTIGEN; SPANX B ANTIGEN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADVANCED CANCER; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; BREAST CARCINOMA; CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COLON CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LEUKOCYTE; LUNG CARCINOMA; MELANOMA; METASTASIS; OVARY CARCINOMA; PRE T LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN FAMILY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPERM; TUMOR CELL DESTRUCTION; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANTIGENS, NEOPLASM; CANCER VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNODOMINANT EPITOPES; MOLECULAR SEQUENCE DATA; NEOPLASMS; NUCLEAR PROTEINS;

EID: 63449126598     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-1290     Document Type: Article

References (21)

1. Kouprina N, Mullokandov M, Rogozin IB, et al. The SPANX gene family of cancer/testis-specific antigens: rapid evolution and amplification in African great apes and hominids. Proc Natl Acad Sci U S A 2004;101: 3077-82.
2. Zendman AJ, Zschocke J, van Kraats AA, et al. The human SPANX multigene family: genomic organization, alignment and expression in male germ cells and tumor cell lines. Gene 2003;309:125-33.
3. Kouprina N, Pavlicek A, NoskovVN, et al. Dynamic structure of the SPANX gene cluster mapped to the prostate cancer susceptibility locus HPCX at Xq27. Genome Res 2005;15:1477-86.
4. WestbrookVA, Schoppee PD, Vanage GR, et al. Hominoid-specific SPANXA/D genes demonstrate differential expression in individuals and protein localization to a distinct nuclear envelope domain during spermatid morphogenesis. Mol Hum Reprod 2006; 12:703-16.
5. WestbrookVA, Diekman AB, Naaby-Hansen S, et al. Differential nuclear localization of the cancer/testis- associated protein, SPAN-X/CTp11, in transfected cells and in 50% of human spermatozoa. Biol Reprod 2001;64:345 -58.
6. Zendman AJ, Cornelissen IM, Weidle UH, Ruiter DJ, van Muijen GN. CTp11, a novel member of the family of human cancer/testis antigens. Cancer Res 1999; 59:6223-9.
7. Wang Z, Zhang Y, Liu H, Salati E, Chiriva-Internati M, Lim SH. Gene expression and immunologic conse-quenceofSPAN-Xb in myeloma andotherhematolog- ic malignancies. Blood 2003;101:955-60.
8. WestbrookVA, Schoppee PD, Diekman AB, et al. Genomic organization, incidence, and localization of the SPAN-X family of cancer-testis antigens in melanoma tumors and cell lines. Clin Cancer Res 2004; 10:101 -12.
9. Bogen B, Lambris JD. Minimum length of an idiotypic peptide and a model for its binding to a major histocompatibility complex class II molecule. EMBO J 1989;8:1947 -52.
10. + T-cell responses. Blood 2006;107:4597-605.
11. Lilljebjorn H, Heidenblad M, Nilsson B, et al. Combined high-resolution array-based comparative ge- nomic hybridization and expression profiling of ETV6/RUNX1-positive acute lymphoblastic leukemias reveal a high incidence of cryptic Xq duplications and identify several putative target genes within the commonly gained region. Leukemia 2007;21:2137-44.
12. Hoek KS, Schlegel NC, Brafford P, et al. Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. Pigment Cell Res 2006;19:290-302.
13. Minn AJ, Gupta GP, Siegel PM, et al. Genes that mediate breast cancer metastasis to lung. Nature 2005;436:518-24.
14. Kouprina N, NoskovVN, Pavlicek A, et al. Evolutionary diversification of SPANX-N sperm protein gene structure and expression. PLoSONE 2007;2:e359.
15. + T cell-mediated protective and therapeutic antitumor immunity. J Immunol 2007;179:1381-8.
16. Su Z, Dannull J, Heiser A, et al. Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells. Cancer Res 2003;63:2127-33.
17. Siegel S, Wagner A, Kabelitz D, et al. Induction of cytotoxicT-cell responses against the oncofetal antigen-immature laminin receptor for the treatment of hematologic malignancies. Blood 2003;102:4416-23.
18. Siegel S,WagnerA, Friedrichs B, et al. Identification of HLA-A*0201-presented Tcell epitopes derived from the oncofetal antigen-immature laminin receptor protein in patients with hematological malignancies. J Immunol 2006;176:6935-44.
19. Salemi M, CalogeroAE, Castiglione R, et al. Expression of SpanX proteins in normal testes and in testicular germ cell tumours. IntJ Androl 2006;29:368-73.
20. Salemi M, Calogero AE, Bosco P, et al. Expression of SpanX mRNA in testicular germ cell tumors. Hum Cell 2006;19:87 -90.
21. + T-cell memory viaTRAIL-mediated activation-induced cell death. Nature 2005; 434:88-93.